IBDEI04L ; ; 20-FEB-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 20, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,5785,2)
 ;;=^334249
 ;;^UTILITY(U,$J,358.3,5786,0)
 ;;=404.93^^55^475^2
 ;;^UTILITY(U,$J,358.3,5786,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5786,1,3,0)
 ;;=3^404.93
 ;;^UTILITY(U,$J,358.3,5786,1,4,0)
 ;;=4^HTN HRT/REN w/ CHR&RF,NOS
 ;;^UTILITY(U,$J,358.3,5786,2)
 ;;=^334251
 ;;^UTILITY(U,$J,358.3,5787,0)
 ;;=404.90^^55^475^4
 ;;^UTILITY(U,$J,358.3,5787,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5787,1,3,0)
 ;;=3^404.90
 ;;^UTILITY(U,$J,358.3,5787,1,4,0)
 ;;=4^HTN HRT/REN w/o CHF/RF,NOS
 ;;^UTILITY(U,$J,358.3,5787,2)
 ;;=^334275
 ;;^UTILITY(U,$J,358.3,5788,0)
 ;;=404.92^^55^475^3
 ;;^UTILITY(U,$J,358.3,5788,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5788,1,3,0)
 ;;=3^404.92
 ;;^UTILITY(U,$J,358.3,5788,1,4,0)
 ;;=4^HTN HRT/REN w/ RENAL FAILURE,NOS
 ;;^UTILITY(U,$J,358.3,5788,2)
 ;;=^334250
 ;;^UTILITY(U,$J,358.3,5789,0)
 ;;=404.01^^55^475^5
 ;;^UTILITY(U,$J,358.3,5789,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5789,1,3,0)
 ;;=3^404.01
 ;;^UTILITY(U,$J,358.3,5789,1,4,0)
 ;;=4^MAL HTN HRT/REN w/ CHF
 ;;^UTILITY(U,$J,358.3,5789,2)
 ;;=^334243
 ;;^UTILITY(U,$J,358.3,5790,0)
 ;;=404.03^^55^475^6
 ;;^UTILITY(U,$J,358.3,5790,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5790,1,3,0)
 ;;=3^404.03
 ;;^UTILITY(U,$J,358.3,5790,1,4,0)
 ;;=4^MAL HTN HRT/REN w/ CHF&RF
 ;;^UTILITY(U,$J,358.3,5790,2)
 ;;=^334245
 ;;^UTILITY(U,$J,358.3,5791,0)
 ;;=404.00^^55^475^8
 ;;^UTILITY(U,$J,358.3,5791,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5791,1,3,0)
 ;;=3^404.00
 ;;^UTILITY(U,$J,358.3,5791,1,4,0)
 ;;=4^MAL HTN HRT/REN w/o CHF&RF
 ;;^UTILITY(U,$J,358.3,5791,2)
 ;;=^334273
 ;;^UTILITY(U,$J,358.3,5792,0)
 ;;=404.02^^55^475^7
 ;;^UTILITY(U,$J,358.3,5792,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5792,1,3,0)
 ;;=3^404.02
 ;;^UTILITY(U,$J,358.3,5792,1,4,0)
 ;;=4^MAL HTN HRT/REN w/ RENAL FAILURE
 ;;^UTILITY(U,$J,358.3,5792,2)
 ;;=^334244
 ;;^UTILITY(U,$J,358.3,5793,0)
 ;;=466.0^^55^476^2
 ;;^UTILITY(U,$J,358.3,5793,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5793,1,3,0)
 ;;=3^466.0
 ;;^UTILITY(U,$J,358.3,5793,1,4,0)
 ;;=4^BRONCHITIS,ACUTE
 ;;^UTILITY(U,$J,358.3,5793,2)
 ;;=^259084
 ;;^UTILITY(U,$J,358.3,5794,0)
 ;;=682.8^^55^476^3
 ;;^UTILITY(U,$J,358.3,5794,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5794,1,3,0)
 ;;=3^682.8
 ;;^UTILITY(U,$J,358.3,5794,1,4,0)
 ;;=4^CELLULITIS, SITE NEC
 ;;^UTILITY(U,$J,358.3,5794,2)
 ;;=^271896
 ;;^UTILITY(U,$J,358.3,5795,0)
 ;;=575.10^^55^476^4
 ;;^UTILITY(U,$J,358.3,5795,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5795,1,3,0)
 ;;=3^575.10
 ;;^UTILITY(U,$J,358.3,5795,1,4,0)
 ;;=4^CHOLECYSTITIS,UNSP
 ;;^UTILITY(U,$J,358.3,5795,2)
 ;;=^23341
 ;;^UTILITY(U,$J,358.3,5796,0)
 ;;=372.39^^55^476^5
 ;;^UTILITY(U,$J,358.3,5796,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5796,1,3,0)
 ;;=3^372.39
 ;;^UTILITY(U,$J,358.3,5796,1,4,0)
 ;;=4^CONJUNCTIVITIS NEC
 ;;^UTILITY(U,$J,358.3,5796,2)
 ;;=^87441
 ;;^UTILITY(U,$J,358.3,5797,0)
 ;;=110.1^^55^476^6
 ;;^UTILITY(U,$J,358.3,5797,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5797,1,3,0)
 ;;=3^110.1
 ;;^UTILITY(U,$J,358.3,5797,1,4,0)
 ;;=4^DERMATOPHYTOSIS OF NAIL
 ;;^UTILITY(U,$J,358.3,5797,2)
 ;;=^33173
 ;;^UTILITY(U,$J,358.3,5798,0)
 ;;=562.11^^55^476^7
 ;;^UTILITY(U,$J,358.3,5798,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5798,1,3,0)
 ;;=3^562.11
 ;;^UTILITY(U,$J,358.3,5798,1,4,0)
 ;;=4^DIVERTICULITIS
 ;;^UTILITY(U,$J,358.3,5798,2)
 ;;=^270274
 ;;^UTILITY(U,$J,358.3,5799,0)
 ;;=424.99^^55^476^8
 ;;^UTILITY(U,$J,358.3,5799,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5799,1,3,0)
 ;;=3^424.99
 ;;^UTILITY(U,$J,358.3,5799,1,4,0)
 ;;=4^ENDOCARDITIS NEC
 ;;^UTILITY(U,$J,358.3,5799,2)
 ;;=^87573
 ;;^UTILITY(U,$J,358.3,5800,0)
 ;;=707.15^^55^476^9
 ;;^UTILITY(U,$J,358.3,5800,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5800,1,3,0)
 ;;=3^707.15
 ;;^UTILITY(U,$J,358.3,5800,1,4,0)
 ;;=4^FOOT ULCER
 ;;^UTILITY(U,$J,358.3,5800,2)
 ;;=^322148
 ;;^UTILITY(U,$J,358.3,5801,0)
 ;;=558.9^^55^476^10
 ;;^UTILITY(U,$J,358.3,5801,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5801,1,3,0)
 ;;=3^558.9
 ;;^UTILITY(U,$J,358.3,5801,1,4,0)
 ;;=4^GASTROENTERITIS
 ;;^UTILITY(U,$J,358.3,5801,2)
 ;;=^87311
 ;;^UTILITY(U,$J,358.3,5802,0)
 ;;=042.^^55^476^1
 ;;^UTILITY(U,$J,358.3,5802,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5802,1,3,0)
 ;;=3^042.
 ;;^UTILITY(U,$J,358.3,5802,1,4,0)
 ;;=4^AIDS (SYMPTOMATIC)
 ;;^UTILITY(U,$J,358.3,5802,2)
 ;;=^266500
 ;;^UTILITY(U,$J,358.3,5803,0)
 ;;=V08.^^55^476^11
 ;;^UTILITY(U,$J,358.3,5803,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5803,1,3,0)
 ;;=3^V08.
 ;;^UTILITY(U,$J,358.3,5803,1,4,0)
 ;;=4^HIV+ (ASYMPTOMATIC)
 ;;^UTILITY(U,$J,358.3,5803,2)
 ;;=^303392
 ;;^UTILITY(U,$J,358.3,5804,0)
 ;;=487.1^^55^476^12
 ;;^UTILITY(U,$J,358.3,5804,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5804,1,3,0)
 ;;=3^487.1
 ;;^UTILITY(U,$J,358.3,5804,1,4,0)
 ;;=4^INFLUENZA
 ;;^UTILITY(U,$J,358.3,5804,2)
 ;;=^63125
 ;;^UTILITY(U,$J,358.3,5805,0)
 ;;=730.00^^55^476^13
 ;;^UTILITY(U,$J,358.3,5805,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5805,1,3,0)
 ;;=3^730.00
 ;;^UTILITY(U,$J,358.3,5805,1,4,0)
 ;;=4^OSTEOMYELITIS
 ;;^UTILITY(U,$J,358.3,5805,2)
 ;;=^272612
 ;;^UTILITY(U,$J,358.3,5806,0)
 ;;=382.9^^55^476^14
 ;;^UTILITY(U,$J,358.3,5806,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5806,1,3,0)
 ;;=3^382.9
 ;;^UTILITY(U,$J,358.3,5806,1,4,0)
 ;;=4^OTITIS MEDIA NOS
 ;;^UTILITY(U,$J,358.3,5806,2)
 ;;=^123967
 ;;^UTILITY(U,$J,358.3,5807,0)
 ;;=614.9^^55^476^15
 ;;^UTILITY(U,$J,358.3,5807,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5807,1,3,0)
 ;;=3^614.9
 ;;^UTILITY(U,$J,358.3,5807,1,4,0)
 ;;=4^PELVIC INFLAMMATORY DISEASE
 ;;^UTILITY(U,$J,358.3,5807,2)
 ;;=^3537
 ;;^UTILITY(U,$J,358.3,5808,0)
 ;;=462.^^55^476^16
 ;;^UTILITY(U,$J,358.3,5808,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5808,1,3,0)
 ;;=3^462.
 ;;^UTILITY(U,$J,358.3,5808,1,4,0)
 ;;=4^PHARYNGITIS
 ;;^UTILITY(U,$J,358.3,5808,2)
 ;;=^2653
 ;;^UTILITY(U,$J,358.3,5809,0)
 ;;=486.^^55^476^17
 ;;^UTILITY(U,$J,358.3,5809,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5809,1,3,0)
 ;;=3^486.
 ;;^UTILITY(U,$J,358.3,5809,1,4,0)
 ;;=4^PNEUMONIA
 ;;^UTILITY(U,$J,358.3,5809,2)
 ;;=^95632
 ;;^UTILITY(U,$J,358.3,5810,0)
 ;;=590.80^^55^476^18
 ;;^UTILITY(U,$J,358.3,5810,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5810,1,3,0)
 ;;=3^590.80
 ;;^UTILITY(U,$J,358.3,5810,1,4,0)
 ;;=4^PYELONEPHRITIS NOS
 ;;^UTILITY(U,$J,358.3,5810,2)
 ;;=^101463
 ;;^UTILITY(U,$J,358.3,5811,0)
 ;;=711.00^^55^476^19
 ;;^UTILITY(U,$J,358.3,5811,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5811,1,3,0)
 ;;=3^711.00
 ;;^UTILITY(U,$J,358.3,5811,1,4,0)
 ;;=4^SEPTIC JOINT
 ;;^UTILITY(U,$J,358.3,5811,2)
 ;;=^263780
 ;;^UTILITY(U,$J,358.3,5812,0)
 ;;=461.8^^55^476^20
 ;;^UTILITY(U,$J,358.3,5812,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5812,1,3,0)
 ;;=3^461.8
 ;;^UTILITY(U,$J,358.3,5812,1,4,0)
 ;;=4^SINUSITIS,ACUTE
 ;;^UTILITY(U,$J,358.3,5812,2)
 ;;=^269865
 ;;^UTILITY(U,$J,358.3,5813,0)
 ;;=473.8^^55^476^21
 ;;^UTILITY(U,$J,358.3,5813,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5813,1,3,0)
 ;;=3^473.8
 ;;^UTILITY(U,$J,358.3,5813,1,4,0)
 ;;=4^SINUSITIS,CHRONIC
 ;;^UTILITY(U,$J,358.3,5813,2)
 ;;=^269890
 ;;^UTILITY(U,$J,358.3,5814,0)
 ;;=463.^^55^476^22
 ;;^UTILITY(U,$J,358.3,5814,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5814,1,3,0)
 ;;=3^463.
 ;;^UTILITY(U,$J,358.3,5814,1,4,0)
 ;;=4^TONSILLITIS
 ;;^UTILITY(U,$J,358.3,5814,2)
 ;;=^2695
 ;;^UTILITY(U,$J,358.3,5815,0)
 ;;=011.90^^55^476^23
 ;;^UTILITY(U,$J,358.3,5815,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5815,1,3,0)
 ;;=3^011.90
 ;;^UTILITY(U,$J,358.3,5815,1,4,0)
 ;;=4^TUBERCULOSIS
 ;;^UTILITY(U,$J,358.3,5815,2)
 ;;=^122756
 ;;^UTILITY(U,$J,358.3,5816,0)
 ;;=465.9^^55^476^24
 ;;^UTILITY(U,$J,358.3,5816,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5816,1,3,0)
 ;;=3^465.9
 ;;^UTILITY(U,$J,358.3,5816,1,4,0)
 ;;=4^URI
 ;;^UTILITY(U,$J,358.3,5816,2)
 ;;=^269878
 ;;^UTILITY(U,$J,358.3,5817,0)
 ;;=599.0^^55^476^25
 ;;^UTILITY(U,$J,358.3,5817,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5817,1,3,0)
 ;;=3^599.0
 ;;^UTILITY(U,$J,358.3,5817,1,4,0)
 ;;=4^UTI
 ;;^UTILITY(U,$J,358.3,5817,2)
 ;;=^124436
 ;;^UTILITY(U,$J,358.3,5818,0)
 ;;=616.10^^55^476^26
 ;;^UTILITY(U,$J,358.3,5818,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5818,1,3,0)
 ;;=3^616.10
 ;;^UTILITY(U,$J,358.3,5818,1,4,0)
 ;;=4^VAGINITIS NOS
 ;;^UTILITY(U,$J,358.3,5818,2)
 ;;=^125233
 ;;^UTILITY(U,$J,358.3,5819,0)
 ;;=277.30^^55^477^1
 ;;^UTILITY(U,$J,358.3,5819,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5819,1,3,0)
 ;;=3^277.30
 ;;^UTILITY(U,$J,358.3,5819,1,4,0)
 ;;=4^AMYLOIDOSIS NOS
 ;;^UTILITY(U,$J,358.3,5819,2)
 ;;=^334185
 ;;^UTILITY(U,$J,358.3,5820,0)
 ;;=277.31^^55^477^3
 ;;^UTILITY(U,$J,358.3,5820,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5820,1,3,0)
 ;;=3^277.31
 ;;^UTILITY(U,$J,358.3,5820,1,4,0)
 ;;=4^FAM MEDITERRANEAN FEVER
 ;;^UTILITY(U,$J,358.3,5820,2)
 ;;=^189367
 ;;^UTILITY(U,$J,358.3,5821,0)
 ;;=277.39^^55^477^2
 ;;^UTILITY(U,$J,358.3,5821,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5821,1,3,0)
 ;;=3^277.39
 ;;^UTILITY(U,$J,358.3,5821,1,4,0)
 ;;=4^AMYLOIDOSIS,OTHER
 ;;^UTILITY(U,$J,358.3,5821,2)
 ;;=^334034
 ;;^UTILITY(U,$J,358.3,5822,0)
 ;;=446.21^^55^477^4
 ;;^UTILITY(U,$J,358.3,5822,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5822,1,3,0)
 ;;=3^446.21
 ;;^UTILITY(U,$J,358.3,5822,1,4,0)
 ;;=4^GOODPASTURE'S SYNDROME
 ;;^UTILITY(U,$J,358.3,5822,2)
 ;;=^52601^583.81
 ;;^UTILITY(U,$J,358.3,5823,0)
 ;;=580.0^^55^477^8
 ;;^UTILITY(U,$J,358.3,5823,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5823,1,3,0)
 ;;=3^580.0
 ;;^UTILITY(U,$J,358.3,5823,1,4,0)
 ;;=4^NEPHRITIS,AC PROLIFERATIVE
 ;;^UTILITY(U,$J,358.3,5823,2)
 ;;=^270338
 ;;^UTILITY(U,$J,358.3,5824,0)
 ;;=580.4^^55^477^9
 ;;^UTILITY(U,$J,358.3,5824,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5824,1,3,0)
 ;;=3^580.4
 ;;^UTILITY(U,$J,358.3,5824,1,4,0)
 ;;=4^NEPHRITIS,AC RAPIDLY PROGR
